Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

Overcome complex development challenges in your Zika vaccine trial

As infectious diseases such as the Zika virus continue to threaten public health, it’s essential that you, as a vaccine developer, work closely with a laboratory partner in order to avoid challenges along the drug development continuum.

Download our new insight brief, Zika Vaccine Research: Complex Steps toward a Critical Need, to discover 5 key questions that should be asked prior to beginning your vaccine study, concerning:
  • Vaccine immunogenicity
  • Efficacy
  • Exposure to related viruses
Q2 Solutions has a geographic footprint, scientific and therapeutic expertise, and deep understanding of global, regional and local requirements for vaccine and anti-infective clinical trials. Learn more about how we can be your trusted partner for vaccine development.
Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Q2 Solutions Anti-infective and Vaccine Development Services

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Read More